Searching PubMed for “Clinical Trial” and checking full-text availability…
for “Clinical Trial” · Showing 7,601–7,620 · 2060 ms
Bassily S, El-Masry N A, Trabolsi B, +1 more·Annals of tropical medicine and parasitology
Abstract not available
Ledermann D·Schweizerische Monatsschrift fur Zahnheilkunde = Revue mensuelle suisse d'odonto-stomatologie
Abstract not available
Hohmeister R·Fortschritte der Medizin
Abstract not available
Stadtler P·Osterreichische Zeitschrift fur Stomatologie
Abstract not available
Lancet (London, England)
Abstract not available
McCormick M S, Thomas J N·Clinical otolaryngology and allied sciences
Abstract not available
Borutta A·Stomatologie der DDR
Abstract not available
Maskens A P, Armand J P, Lacave A J, +3 more·Cancer treatment reports
Abstract not available
Markus A F, Gough D·International journal of oral surgery
A double-blind trial comparing the analgesic efficacy of Suprofen 200 mg with aspirin 750 mg was carried out on 120 patients. There was no statistical difference between the two, though Suprofen had fewer side effects and could be used in circumstances where aspirin is contra-indicated.
Marcial V A, Hanley J A, Chang C, +2 more·International journal of radiation oncology, biology, physics
Abstract not available
Guglielmi G, Mammarella A·La Clinica terapeutica
Abstract not available
Distante A, Maseri A, Severi S, +2 more·The American journal of cardiology
Abstract not available
de Brito F S, Pereira M H·Arquivos brasileiros de cardiologia
Abstract not available
Koch-Henriksen N, Sehested P·Acta neurologica Scandinavica
In a double-blind cross-over trial with placebo, FPL 57787, a chromone derivate, was tested on 15 patients as a prophylactic against migraine. There was found to be no effect.
Huskisson E C·The Practitioner
Abstract not available
Shepherd M·Progress in neuro-psychopharmacology
1. A controlled clinical trial has shown oral pimozide to be clinically at least as effective as fluphenazine decanoate in the continuation treatment of schizophrenia. 2. Pimozide was also associated with more favourable measures of social outcome. 3. Some implications of these findings are discussed.
Naylor M N, Glass R L·Caries research
Abstract not available
Camarri E, Marcolongo R, Fici F·International journal of clinical pharmacology and biopharmacy
Administration of chenodeoxycholic acid (CDCA), 200 mg/day, for 5 days to patients with primary hypertriglyceridemia reduced by 34% the serum triglycerides concentration. Reduction after CDCA is statistically significant vs. the placebo. Even after a short time of CDCA administration, the pharmacological effect is clea…
European journal of cancer
Abstract not available
Ourgaud A G, Chagnon A M, Roux J J·Bulletin des societes d'ophtalmologie de France
Abstract not available